APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Botanical Drug

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.

Selected research

Market Outlook & Growth Opportunities

Global Botanical Drug Market Outlook and Growth Opportunities 2026

Report ID 173972070428 December 2025197 pages

Choose your research edition.

Industry ResearchBotanical Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Botanical Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Botanical Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Botanical Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Botanical Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.

Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.

Read the full market overview

The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.

Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.

This report provides an overview of the global Botanical Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Botanical Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Botanical Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Botanical Drug market.

Botanical Drug Segment by Company

Buchang Pharmaceuticals

China TCM

Tsumura

Schwabe

Tong Ren Tang

Jumpcan Pharmaceutical

Guangzhou Baiyunshan Pharmaceutical

Yunnan Baiyao

Tasly Holding Group

Bionorica Se

Huarun 999

Taiji

Weleda

Kwangdong

GW Pharmaceuticals

Botanical Drug Segment by Type

Prescription Drug

OTC

Botanical Drug Segment by Application

Cardiovascular

Tumor

Respiratory System

Others

Botanical Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Botanical Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Botanical Drug key companies, revenue, market share, and recent developments.

3. To split the Botanical Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Botanical Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Botanical Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Botanical Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Botanical Drug industry.

Chapter 3: Detailed analysis of Botanical Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Botanical Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Botanical Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Botanical Drug Industry Trends Table 2. Botanical Drug Industry Drivers Table 3. Botanical Drug Industry Opportunities and Challenges Table 4. Botanical Drug Industry Restraints Table 5. Global Botanical Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Botanical Drug Revenue Share by Company (2021-2026) Table 7. Global Botanical Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Botanical Drug Key Company Manufacturing Base & Headquarters Table 9. Global Botanical Drug Company, Product Type & Application Table 10. Global Botanical Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Botanical Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Prescription Drug Table 15. Significant Companies of OTC Table 16. Global Botanical Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Botanical Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Botanical Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Botanical Drug Sales Value Share by Type (2021-2026) Table 20. Global Botanical Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cardiovascular Table 22. Significant Companies of Tumor Table 23. Significant Companies of Respiratory System Table 24. Significant Companies of Others Table 25. Global Botanical Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Botanical Drug Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Botanical Drug Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Botanical Drug Sales Value Share by Application (2021-2026) Table 29. Global Botanical Drug Sales Value Share by Application (2027-2032) Table 30. Global Botanical Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Botanical Drug Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Botanical Drug Sales Value Share by Region (2021-2026) Table 33. Global Botanical Drug Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Botanical Drug Sales Value Share by Region (2027-2032) Table 35. Global Botanical Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Botanical Drug Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Botanical Drug Sales Value Market Share by Country (2021-2026) Table 38. Global Botanical Drug Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Botanical Drug Sales Value Market Share by Country (2027-2032) Table 40. Buchang Pharmaceuticals Company Information Table 41. Buchang Pharmaceuticals Business Overview Table 42. Buchang Pharmaceuticals Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Buchang Pharmaceuticals Botanical Drug Product Portfolio Table 44. Buchang Pharmaceuticals Recent Development Table 45. China TCM Company Information Table 46. China TCM Business Overview Table 47. China TCM Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. China TCM Botanical Drug Product Portfolio Table 49. China TCM Recent Development Table 50. Tsumura Company Information Table 51. Tsumura Business Overview Table 52. Tsumura Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Tsumura Botanical Drug Product Portfolio Table 54. Tsumura Recent Development Table 55. Schwabe Company Information Table 56. Schwabe Business Overview Table 57. Schwabe Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Schwabe Botanical Drug Product Portfolio Table 59. Schwabe Recent Development Table 60. Tong Ren Tang Company Information Table 61. Tong Ren Tang Business Overview Table 62. Tong Ren Tang Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Tong Ren Tang Botanical Drug Product Portfolio Table 64. Tong Ren Tang Recent Development Table 65. Jumpcan Pharmaceutical Company Information Table 66. Jumpcan Pharmaceutical Business Overview Table 67. Jumpcan Pharmaceutical Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Jumpcan Pharmaceutical Botanical Drug Product Portfolio Table 69. Jumpcan Pharmaceutical Recent Development Table 70. Guangzhou Baiyunshan Pharmaceutical Company Information Table 71. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 72. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio Table 74. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 75. Yunnan Baiyao Company Information Table 76. Yunnan Baiyao Business Overview Table 77. Yunnan Baiyao Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Yunnan Baiyao Botanical Drug Product Portfolio Table 79. Yunnan Baiyao Recent Development Table 80. Tasly Holding Group Company Information Table 81. Tasly Holding Group Business Overview Table 82. Tasly Holding Group Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Tasly Holding Group Botanical Drug Product Portfolio Table 84. Tasly Holding Group Recent Development Table 85. Bionorica Se Company Information Table 86. Bionorica Se Business Overview Table 87. Bionorica Se Botanical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Bionorica Se Botanical Drug Product Portfolio Table 89. Bionorica Se Recent Development Table 90. Huarun 999 Company Information Table 91. Huarun 999 Business Overview Table 92. Huarun 999 Botanical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Huarun 999 Botanical Drug Product Portfolio Table 94. Huarun 999 Recent Development Table 95. Taiji Company Information Table 96. Taiji Business Overview Table 97. Taiji Botanical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Taiji Botanical Drug Product Portfolio Table 99. Taiji Recent Development Table 100. Weleda Company Information Table 101. Weleda Business Overview Table 102. Weleda Botanical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Weleda Botanical Drug Product Portfolio Table 104. Weleda Recent Development Table 105. Kwangdong Company Information Table 106. Kwangdong Business Overview Table 107. Kwangdong Botanical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Kwangdong Botanical Drug Product Portfolio Table 109. Kwangdong Recent Development Table 110. GW Pharmaceuticals Company Information Table 111. GW Pharmaceuticals Business Overview Table 112. GW Pharmaceuticals Botanical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. GW Pharmaceuticals Botanical Drug Product Portfolio Table 114. GW Pharmaceuticals Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Botanical Drug Product Image Figure 2. Global Botanical Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Botanical Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Botanical Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Prescription Drug Image Figure 8. OTC Image Figure 9. Global Botanical Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Botanical Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Botanical Drug Sales Value Share by Type (2021-2032) Figure 12. Cardiovascular Image Figure 13. Tumor Image Figure 14. Respiratory System Image Figure 15. Others Image Figure 16. Global Botanical Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Botanical Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Botanical Drug Sales Value Share by Application (2021-2032) Figure 19. Global Botanical Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Botanical Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Botanical Drug Sales Value (2021-2032) & (US$ Million) Figure 22. North America Botanical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Botanical Drug Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Botanical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Botanical Drug Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Botanical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Botanical Drug Sales Value (2021-2032) & (US$ Million) Figure 28. South America Botanical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Botanical Drug Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Botanical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Botanical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Botanical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Botanical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drug
  • OTC
Applications
  • Cardiovascular
  • Tumor
  • Respiratory System
  • Others
Companies covered
  • Buchang Pharmaceuticals
  • China TCM
  • Tsumura
  • Schwabe
  • Tong Ren Tang
  • Jumpcan Pharmaceutical
  • Guangzhou Baiyunshan Pharmaceutical
  • Yunnan Baiyao
  • Tasly Holding Group
  • Bionorica Se
  • Huarun 999
  • Taiji
  • Weleda
  • Kwangdong
  • GW Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Botanical Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Botanical Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Botanical Drug Market Dynamics
  1. 2.1 Botanical Drug Industry Trends
  2. 2.2 Botanical Drug Industry Drivers
  3. 2.3 Botanical Drug Industry Opportunities and Challenges
  4. 2.4 Botanical Drug Industry Restraints
3 Botanical Drug Market by Company
  1. 3.1 Global Botanical Drug Company Revenue Ranking in 2025
  2. 3.2 Global Botanical Drug Revenue by Company (2021-2026)
  3. 3.3 Global Botanical Drug Company Ranking (2024-2026)
  4. 3.4 Global Botanical Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Botanical Drug Company Product Type and Application
  6. 3.6 Global Botanical Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Botanical Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Botanical Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Botanical Drug Market by Type
  1. 4.1 Botanical Drug Type Introduction
  2. 4.1.1 Prescription Drug
  3. 4.1.2 OTC
  4. 4.2 Global Botanical Drug Sales Value by Type
  5. 4.2.1 Global Botanical Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Botanical Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Botanical Drug Sales Value Share by Type (2021-2032)
5 Botanical Drug Market by Application
  1. 5.1 Botanical Drug Application Introduction
  2. 5.1.1 Cardiovascular
  3. 5.1.2 Tumor
  4. 5.1.3 Respiratory System
  5. 5.1.4 Others
  6. 5.2 Global Botanical Drug Sales Value by Application
  7. 5.2.1 Global Botanical Drug Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Botanical Drug Sales Value by Application (2021-2032)
  9. 5.2.3 Global Botanical Drug Sales Value Share by Application (2021-2032)
6 Botanical Drug Regional Value Analysis
  1. 6.1 Global Botanical Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Botanical Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Botanical Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Botanical Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Botanical Drug Sales Value (2021-2032)
  7. 6.3.2 North America Botanical Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Botanical Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Botanical Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Botanical Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Botanical Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Botanical Drug Sales Value (2021-2032)
  16. 6.6.2 South America Botanical Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Botanical Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Botanical Drug Sales Value Share by Country, 2025 VS 2032
7 Botanical Drug Country-level Value Analysis
  1. 7.1 Global Botanical Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Botanical Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Botanical Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Botanical Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Botanical Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Botanical Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Botanical Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Botanical Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Botanical Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Botanical Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Botanical Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Botanical Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Botanical Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Botanical Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Botanical Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Botanical Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Botanical Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Botanical Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Botanical Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Botanical Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Botanical Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Botanical Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Botanical Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Botanical Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Botanical Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Botanical Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Botanical Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Botanical Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Botanical Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Botanical Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Botanical Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Botanical Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Botanical Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Botanical Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Botanical Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Botanical Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Botanical Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Botanical Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Botanical Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Botanical Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Botanical Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Botanical Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Botanical Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Botanical Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Botanical Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Botanical Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Botanical Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Botanical Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Botanical Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Botanical Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Botanical Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Botanical Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Botanical Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Botanical Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Botanical Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Botanical Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Botanical Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Botanical Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Botanical Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Botanical Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Botanical Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Botanical Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Botanical Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Botanical Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Botanical Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Botanical Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Botanical Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Botanical Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Botanical Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Botanical Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Botanical Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Botanical Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Botanical Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Botanical Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Botanical Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Botanical Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Botanical Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Botanical Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Botanical Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Botanical Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Botanical Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Botanical Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Botanical Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Botanical Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Botanical Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Botanical Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Botanical Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Botanical Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Buchang Pharmaceuticals
  2. 8.1.1 Buchang Pharmaceuticals Company Information
  3. 8.1.2 Buchang Pharmaceuticals Business Overview
  4. 8.1.3 Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Buchang Pharmaceuticals Botanical Drug Product Portfolio
  6. 8.1.5 Buchang Pharmaceuticals Recent Developments
  7. 8.2 China TCM
  8. 8.2.1 China TCM Company Information
  9. 8.2.2 China TCM Business Overview
  10. 8.2.3 China TCM Botanical Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 China TCM Botanical Drug Product Portfolio
  12. 8.2.5 China TCM Recent Developments
  13. 8.3 Tsumura
  14. 8.3.1 Tsumura Company Information
  15. 8.3.2 Tsumura Business Overview
  16. 8.3.3 Tsumura Botanical Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tsumura Botanical Drug Product Portfolio
  18. 8.3.5 Tsumura Recent Developments
  19. 8.4 Schwabe
  20. 8.4.1 Schwabe Company Information
  21. 8.4.2 Schwabe Business Overview
  22. 8.4.3 Schwabe Botanical Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Schwabe Botanical Drug Product Portfolio
  24. 8.4.5 Schwabe Recent Developments
  25. 8.5 Tong Ren Tang
  26. 8.5.1 Tong Ren Tang Company Information
  27. 8.5.2 Tong Ren Tang Business Overview
  28. 8.5.3 Tong Ren Tang Botanical Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tong Ren Tang Botanical Drug Product Portfolio
  30. 8.5.5 Tong Ren Tang Recent Developments
  31. 8.6 Jumpcan Pharmaceutical
  32. 8.6.1 Jumpcan Pharmaceutical Company Information
  33. 8.6.2 Jumpcan Pharmaceutical Business Overview
  34. 8.6.3 Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jumpcan Pharmaceutical Botanical Drug Product Portfolio
  36. 8.6.5 Jumpcan Pharmaceutical Recent Developments
  37. 8.7 Guangzhou Baiyunshan Pharmaceutical
  38. 8.7.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  39. 8.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  40. 8.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio
  42. 8.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  43. 8.8 Yunnan Baiyao
  44. 8.8.1 Yunnan Baiyao Company Information
  45. 8.8.2 Yunnan Baiyao Business Overview
  46. 8.8.3 Yunnan Baiyao Botanical Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yunnan Baiyao Botanical Drug Product Portfolio
  48. 8.8.5 Yunnan Baiyao Recent Developments
  49. 8.9 Tasly Holding Group
  50. 8.9.1 Tasly Holding Group Company Information
  51. 8.9.2 Tasly Holding Group Business Overview
  52. 8.9.3 Tasly Holding Group Botanical Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tasly Holding Group Botanical Drug Product Portfolio
  54. 8.9.5 Tasly Holding Group Recent Developments
  55. 8.10 Bionorica Se
  56. 8.10.1 Bionorica Se Company Information
  57. 8.10.2 Bionorica Se Business Overview
  58. 8.10.3 Bionorica Se Botanical Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bionorica Se Botanical Drug Product Portfolio
  60. 8.10.5 Bionorica Se Recent Developments
  61. 8.11 Huarun 999
  62. 8.11.1 Huarun 999 Company Information
  63. 8.11.2 Huarun 999 Business Overview
  64. 8.11.3 Huarun 999 Botanical Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Huarun 999 Botanical Drug Product Portfolio
  66. 8.11.5 Huarun 999 Recent Developments
  67. 8.12 Taiji
  68. 8.12.1 Taiji Company Information
  69. 8.12.2 Taiji Business Overview
  70. 8.12.3 Taiji Botanical Drug Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Taiji Botanical Drug Product Portfolio
  72. 8.12.5 Taiji Recent Developments
  73. 8.13 Weleda
  74. 8.13.1 Weleda Company Information
  75. 8.13.2 Weleda Business Overview
  76. 8.13.3 Weleda Botanical Drug Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Weleda Botanical Drug Product Portfolio
  78. 8.13.5 Weleda Recent Developments
  79. 8.14 Kwangdong
  80. 8.14.1 Kwangdong Company Information
  81. 8.14.2 Kwangdong Business Overview
  82. 8.14.3 Kwangdong Botanical Drug Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kwangdong Botanical Drug Product Portfolio
  84. 8.14.5 Kwangdong Recent Developments
  85. 8.15 GW Pharmaceuticals
  86. 8.15.1 GW Pharmaceuticals Company Information
  87. 8.15.2 GW Pharmaceuticals Business Overview
  88. 8.15.3 GW Pharmaceuticals Botanical Drug Revenue and Gross Margin (2021-2026)
  89. 8.15.4 GW Pharmaceuticals Botanical Drug Product Portfolio
  90. 8.15.5 GW Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst